193 related articles for article (PubMed ID: 18087085)
21. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy.
Katoch K; Katoch VM; Natrajan M; Bhatia AS; Sreevatsa ; Gupta UD; Sharma VD; Shivannavar CT; Patil MA; Bharadwaj VP
Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):202-12. PubMed ID: 7602215
[TBL] [Abstract][Full Text] [Related]
22. Effect of cutaneous cell-mediated immune response to rIFN gamma on Mycobacterium leprae viability in the lesions of lepromatous leprosy.
Damasco MH; Sarno EN; Lobão AS; Alvarenga FB; Porto JA; Rosankaimer F; Kaplan G
Braz J Med Biol Res; 1992; 25(5):457-65. PubMed ID: 1342221
[TBL] [Abstract][Full Text] [Related]
23. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
Kar HK; Sharma P
Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
[TBL] [Abstract][Full Text] [Related]
24. Correlation viability/morphology in Mycobacterium leprae.
Silva MT; Macedo PM; Portaels F; Pattyn SR
Acta Leprol; 1984; 2(2-4):281-91. PubMed ID: 6398588
[TBL] [Abstract][Full Text] [Related]
25. [Leprosy in Brazil].
Araújo MG
Rev Soc Bras Med Trop; 2003; 36(3):373-82. PubMed ID: 12908039
[TBL] [Abstract][Full Text] [Related]
26. A simplified reverse transcriptase PCR for rapid detection of Mycobacterium leprae in skin specimens.
Phetsuksiri B; Rudeeaneksin J; Supapkul P; Wachapong S; Mahotarn K; Brennan PJ
FEMS Immunol Med Microbiol; 2006 Dec; 48(3):319-28. PubMed ID: 17052269
[TBL] [Abstract][Full Text] [Related]
27. A comparative and combinatorial study on two serological assays for detection of Mycobacterium leprae infection.
Parkash O; Girdhar BK
Acta Leprol; 2001-2002; 12(2):63-9. PubMed ID: 12136738
[TBL] [Abstract][Full Text] [Related]
28. Experience and lessons from the use of lepromin and Mycobacterium leprae-specific serology.
Sengupta U
Lepr Rev; 2000 Dec; 71 Suppl():S63-6. PubMed ID: 11201890
[TBL] [Abstract][Full Text] [Related]
29. Clinical and histopathological correlation in the classification of leprosy.
Bhatia AS; Katoch K; Narayanan RB; Ramu G; Mukherjee A; Lavania RK
Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):433-8. PubMed ID: 8228443
[TBL] [Abstract][Full Text] [Related]
30. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?
Ebenezer GJ; Daniel S; Norman G; Daniel E; Job CK
Indian J Lepr; 2004; 76(3):199-206. PubMed ID: 15835604
[TBL] [Abstract][Full Text] [Related]
31. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
Levy L; Ji B
Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
[TBL] [Abstract][Full Text] [Related]
32. Erythrocyte glutathione peroxidase, glutathione reductase activities and blood glutathione content in leprosy.
Prasad CV; Kodliwadmath MV; Kodliwadmath GB
J Infect; 2008 Jun; 56(6):469-73. PubMed ID: 18440071
[TBL] [Abstract][Full Text] [Related]
33. 10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy.
Katoch K; Katoch VM; Natrajan M; Sreevatsa ; Gupta UD; Sharma VD; Shivanavar CT
Vaccine; 2004 Sep; 22(27-28):3649-57. PubMed ID: 15315844
[TBL] [Abstract][Full Text] [Related]
34. Effect of freezing Mycobacterium leprae in tissues.
Dhople AM
Lepr India; 1982 Jul; 54(3):461-70. PubMed ID: 6757579
[TBL] [Abstract][Full Text] [Related]
35. DDS-resistant infection among leprosy patients in the population of Gudiyatham Taluk, South India. Part 3. Prevalence, incidence, risk factors, and interpretation of mouse foot pad test results.
Almeida JG; Chacko CJ; Christian M; Taylor PM; Fritschi EP
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):366-73. PubMed ID: 6685699
[TBL] [Abstract][Full Text] [Related]
36. Use of NASBA RNA amplification for detection of Mycobacterium leprae in skin biopsies from untreated and treated leprosy patients.
van der Vliet GM; Cho SN; Kampirapap K; van Leeuwen J; Schukkink RA; van Gemen B; Das PK; Faber WR; Walsh GP; Klatser PR
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):396-403. PubMed ID: 9030105
[TBL] [Abstract][Full Text] [Related]
37. Early serodiagnosis of leprosy by indirect immunofluorescence.
Abe M; Izumi S; Saito T; Mathur SK
Lepr India; 1976 Jul; 48(3):272-6. PubMed ID: 799209
[TBL] [Abstract][Full Text] [Related]
38. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
[TBL] [Abstract][Full Text] [Related]
39. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy.
Reece ST; Ireton G; Mohamath R; Guderian J; Goto W; Gelber R; Groathouse N; Spencer J; Brennan P; Reed SG
Clin Vaccine Immunol; 2006 Mar; 13(3):333-40. PubMed ID: 16522774
[TBL] [Abstract][Full Text] [Related]
40. Comparative study of anti-PGL-1, anti-35 kDa and anti-lipoarabinomannan assays for serodiagnosis of leprosy.
Jayapal V; Selvibai G; Mahalakshmi K; Pushkala ; Regunath K; Subramanian S
Indian J Lepr; 2001; 73(3):229-37. PubMed ID: 11840595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
